CA AB 425

Title: Medi-Cal: pharmacogenomic testing.
Author: David Alvarez

Summary
AB 425, Alvarez. Medi-Cal: pharmacogenomic testing. Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Existing law sets forth a schedule of covered benefits under the Medi-Cal program.This bill would, commencing on July 1, 2024, add pharmacogenomic testing as a covered benefit under Medi-Cal, as specified. The bill would define pharmacogenomic testing as laboratory genetic testing that includes, but is not limited to, a panel test, to identify how a person’s genetics may impact the efficacy, toxicity, and safety of medications.The bill would condition implementation of this benefit coverage on receipt of any necessary federal approvals and the availability of federal financial participation. The bill would authorize the department to implement these provisions through all-county letters or similar instructions.The bill would also make related legislative findings.

Status
Enrolled and presented to the Governor at 3:30 p.m.

Bill Documents
CA AB 425 - 09/18/23 - Enrolled

CA AB 425 - 09/01/23 - Amended Senate

CA AB 425 - 03/30/23 - Amended Assembly

CA AB 425 - 02/06/23 - Introduced

Add To Favorites

Author Details

David Alvarez - D
Assemblyman - State Assembly - CA
Contact this Assemblyman
Visit their Website

Contact Tips

Capital Address:
P.O. Box 942849, 1021 O Street, Suite 5320
Sacramento, CA 94249-0080
9163192080

District Address:
276 Church Ave Ste D
Chula Vista, CA 91910 2729
Phone: 6194988580

State Legislate

Federal Legislate

CA AB 425

Author Details

District Address: